Article

Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters.

Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Joslin Diabetes Center, Boston, Massachusetts, USA.
Nature medicine (Impact Factor: 28.05). 09/2009; 15(8):930-9. DOI: 10.1038/nm.2002
Source: PubMed

ABSTRACT Obesity is accompanied by chronic, low-grade inflammation of adipose tissue, which promotes insulin resistance and type-2 diabetes. These findings raise the question of how fat inflammation can escape the powerful armamentarium of cells and molecules normally responsible for guarding against a runaway immune response. CD4(+) Foxp3(+) T regulatory (T(reg)) cells with a unique phenotype were highly enriched in the abdominal fat of normal mice, but their numbers were strikingly and specifically reduced at this site in insulin-resistant models of obesity. Loss-of-function and gain-of-function experiments revealed that these T(reg) cells influenced the inflammatory state of adipose tissue and, thus, insulin resistance. Cytokines differentially synthesized by fat-resident regulatory and conventional T cells directly affected the synthesis of inflammatory mediators and glucose uptake by cultured adipocytes. These observations suggest that harnessing the anti-inflammatory properties of T(reg) cells to inhibit elements of the metabolic syndrome may have therapeutic potential.

Full-text

Available from: Jongsoon Lee, Jun 15, 2015
3 Followers
 · 
154 Views
  • Frontiers in Immunology 11/2014; 5. DOI:10.3389/fimmu.2014.00590
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Metabolic syndrome (MetS), a cluster of various metabolic conditions, has become epidemic and causes increased morbidity and mortality. The aim of this study was to compare lymphocyte proliferation under two different stimuli, Concanavalin A (ConA) and insulin, in a group of patients with MetS (Group 1) and a healthy group (Group 2). Group 1 consisted of 53 patients who met the diagnostic criteria for MetS. Group 2 consisted of 63 patients without MetS. All individuals were evaluated for lipid profile and glycemia. Lymphocyte extraction and culture were performed for each subject and lymphocyte proliferation was assessed using the Alamar blue technique. There was no gender difference between both groups, but in terms of age, there was a significant difference. The use of Con A at concentrations of 1 and 5 µg/mL induced a high lymphocyte proliferation in both groups. In contrast, when different concentrations of insulin were added, no significant changes in lymphocyte proliferation were observed. However, the proliferation of lymphocytes was significantly higher in Group 1 compared to Group 2 under insulin stimulus, which did not happen under ConA stimulation. Even after age and gender correction, this difference was maintained. The increased lymphocyte proliferative response to insulin in patients with MetS found in this study suggests a role of the lymphocyte response to insulin in the pathophysiology of MetS. This response may be used as an immuno-biological marker for MetS, although further studies to evaluate its clinical usefulness need to be conducted.
    Journal of endocrinological investigation 05/2015; DOI:10.1007/s40618-015-0307-6 · 1.55 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The adaptive expansion of adipose tissue during energy excess involves significant tissue remodeling and angiogenesis that requires controlled local proinflammatory responses. However, sustained adipose tissue inflammation associated with chronic obesity adversely impacts adipose tissue function and is a major instigator of metabolic diseases such as type 2 diabetes. Despite the absence of overt infection in obesity, the adipose tissue of overweight and obese patients is infiltrated with a substantially high frequency of cells of hematopoietic lineage. A large body of evidence suggests that activated innate immune cell subsets chiefly contribute to the persistent state of inflammation and maybe a common mechanism of several obesity-associated chronic diseases. It has been suggested that lipid fluxes in the adipose tissue and the presence of damage-associated molecular patterns serve as a potential trigger for macrophage infiltration and activation. Emerging evidence shows that inflammasomes, the multiprotein platforms that control the activation and secretion of IL-1 beta and IL-18 in adipose tissue, impact the adipocyte function and T cell activation. This chapter discusses the mechanisms that regulate inflammasome activation in obesity and dietary and pharmacological approaches to control immune-metabolic interactions that link sustained adiposity to chronic diseases. Copyright (C) 2013 S. Karger AG, Basel
    01/2013: pages 91-95;